{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:39:19Z","timestamp":1777484359384,"version":"3.51.4"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1097\/01.jcp.0000125745.60149.c6","type":"journal-article","created":{"date-parts":[[2004,9,2]],"date-time":"2004-09-02T04:08:23Z","timestamp":1094098103000},"page":"322-334","source":"Crossref","is-referenced-by-count":66,"title":["The Relationship Between Polycystic Ovary Syndrome and Antiepileptic Drugs"],"prefix":"10.1097","volume":"24","author":[{"given":"Natalie","family":"Rasgon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"13","key":"R1-13-20210128","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome.","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"R2-13-20210128","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.med.52.1.401","article-title":"Current concepts in the polycystic ovary syndrome.","volume":"52","author":"Dunaif","year":"2001","journal-title":"Annu Rev Med"},{"issue":"12","key":"R3-13-20210128","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/0003-4819-132-12-200006200-00010","article-title":"The importance of diagnosing the polycystic ovary syndrome.","volume":"132","author":"Lobo","year":"2000","journal-title":"Ann Intern Med"},{"issue":"19","key":"R4-13-20210128","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJM199311043291904","article-title":"Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.","volume":"329","author":"Isojarvi","year":"1993","journal-title":"N Engl J Med"},{"issue":"9371","key":"R6-13-20210128","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma.","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"R7-13-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women.","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"R8-13-20210128","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"R9-13-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0920-1211(00)00139-X","article-title":"Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women.","volume":"41","author":"Bauer","year":"2000","journal-title":"Epilepsy Res"},{"issue":"7","key":"R10-13-20210128","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1210\/jcem.86.7.7633","article-title":"Characterization of reproductive endocrine disorders in women with epilepsy.","volume":"86","author":"Bilo","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"R11-13-20210128","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1093\/humrep\/16.12.2606","article-title":"Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.","volume":"16","author":"Wang","year":"2001","journal-title":"Hum Reprod"},{"issue":"2","key":"R12-13-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000067719","article-title":"Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome.","volume":"54","author":"Bjercke","year":"2002","journal-title":"Gynecol Obstet Investig"},{"issue":"2","key":"R13-13-20210128","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/humrep\/16.2.226","article-title":"Obstetric outcome in women with polycystic ovarian syndrome.","volume":"16","author":"Mikola","year":"2001","journal-title":"Hum Reprod"},{"issue":"1-2","key":"R14-13-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0303-7207(99)00239-7","article-title":"Follicular dynamics in the polycystic ovary syndrome.","volume":"163","author":"Franks","year":"2000","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"R15-13-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/molehr\/4.1.1","article-title":"Aromatase mRNA expression in individual follicles from polycystic ovaries.","volume":"4","author":"Jakimiuk","year":"1998","journal-title":"Mol Hum Reprod"},{"issue":"7","key":"R16-13-20210128","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/oxfordjournals.humrep.a019405","article-title":"Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome.","volume":"11","author":"Takayama","year":"1996","journal-title":"Hum Reprod"},{"issue":"suppl 1","key":"R17-13-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/ajcn\/45.1.277","article-title":"Adipose tissue as a source of hormones.","volume":"45","author":"Siiteri","year":"1987","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"R18-13-20210128","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/humupd\/7.6.522","article-title":"Polycystic ovary syndrome and cancer.","volume":"7","author":"Balen","year":"2001","journal-title":"Hum Reprod Updat"},{"issue":"4","key":"R19-13-20210128","first-page":"403","article-title":"Chronic anovulation syndrome and associated neoplasia.","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"16","key":"R21-13-20210128","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/88.16.1127","article-title":"Case-control study of endogenous steroid hormones and endometrial cancer.","volume":"88","author":"Potischman","year":"1996","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"R22-13-20210128","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"issue":"1","key":"R23-13-20210128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"issue":"1","key":"R24-13-20210128","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1A","key":"R25-13-20210128","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/S0002-9343(99)80057-6","article-title":"Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus.","volume":"98","author":"Dunaif","year":"1995","journal-title":"Am J Med"},{"issue":"4","key":"R26-13-20210128","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/jcem-68-4-715","article-title":"The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women.","volume":"68","author":"Peiris","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"R27-13-20210128","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"issue":"5","key":"R28-13-20210128","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study.","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"R29-13-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.1996.674495.x","article-title":"Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.","volume":"44","author":"Robinson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"R30-13-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.","volume":"37","author":"Conway","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"R31-13-20210128","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"issue":"5","key":"R33-13-20210128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2265.1996.00863.x","article-title":"Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.","volume":"45","author":"Sampson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"R34-13-20210128","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.87.8.8716","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state.","volume":"87","author":"Yildiz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"R35-13-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11886-999-0069-x","article-title":"Fibrinolytic function and coronary risk.","volume":"1","author":"Juhan-Vague","year":"1999","journal-title":"Curr Cardiol Rep"},{"issue":"8469-8470","key":"R36-13-20210128","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(85)92552-8","article-title":"Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone.","volume":"2","author":"Adams","year":"1985","journal-title":"Lancet"},{"issue":"6543","key":"R37-13-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.","volume":"293","author":"Adams","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"8590","key":"R38-13-20210128","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries-a common finding in normal women.","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"issue":"5","key":"R39-13-20210128","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/jcu.1870090504","article-title":"Medical implications of ultrasonically detected polycystic ovaries.","volume":"9","author":"Swanson","year":"1981","journal-title":"J Clin Ultrasound"},{"issue":"1","key":"R40-13-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1479-828X.1994.tb01041.x","article-title":"The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women.","volume":"34","author":"Farquhar","year":"1994","journal-title":"Aust NZ J Obstet Gynaecol"},{"issue":"4","key":"R41-13-20210128","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0015-0282(03)01010-0","article-title":"Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic ovary syndrome is not associated with subfecundity or subfertility.","volume":"80","author":"Hassan","year":"2003","journal-title":"Fertil Steril"},{"issue":"4","key":"R42-13-20210128","first-page":"1158","article-title":"Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries.","volume":"79","author":"Gilling-Smith","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"R43-13-20210128","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.0.124R001","article-title":"Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells.","volume":"124","author":"Singh","year":"1990","journal-title":"J Endocrinol"},{"issue":"3","key":"R44-13-20210128","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2265.1993.tb02378.x","article-title":"Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction.","volume":"39","author":"Hamilton-Fairley","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"R45-13-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2007-1016295","article-title":"Insulin-like growth factor binding proteins: do they play a role in polycystic ovary syndrome?","volume":"15","author":"Cataldo","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"issue":"suppl 3","key":"R46-13-20210128","doi-asserted-by":"crossref","first-page":"73S","DOI":"10.1097\/00006250-198409001-00019","article-title":"Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca.","volume":"64","author":"Barbieri","year":"1984","journal-title":"Obstet Gynecol"},{"issue":"2","key":"R47-13-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0015-0282(16)55675-1","article-title":"Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin.","volume":"59","author":"Bergh","year":"1993","journal-title":"Fertil Steril"},{"issue":"7154","key":"R48-13-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bmj.317.7154.329","article-title":"Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology.","volume":"317","author":"Hopkinson","year":"1998","journal-title":"BMJ"},{"issue":"9","key":"R49-13-20210128","first-page":"3110","article-title":"Selective insulin resistance in the polycystic ovary syndrome.","volume":"84","author":"Book","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"R50-13-20210128","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0026-0495(98)90348-1","article-title":"Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome.","volume":"47","author":"Ciaraldi","year":"1998","journal-title":"Metabolism"},{"issue":"2","key":"R51-13-20210128","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.","volume":"96","author":"Dunaif","year":"1995","journal-title":"J Clin Invest"},{"issue":"3","key":"R52-13-20210128","first-page":"942","article-title":"Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"R53-13-20210128","first-page":"217","article-title":"Phenotype and genotype in polycystic ovary syndrome.","volume":"53","author":"Legro","year":"1998","journal-title":"Recent Prog Horm Res"},{"issue":"25","key":"R54-13-20210128","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1073\/pnas.95.25.14956","article-title":"Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.","volume":"95","author":"Legro","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"R55-13-20210128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archneur.1986.00520040029014","article-title":"Reproductive endocrine disorders in women with partial seizures of temporal lobe origin.","volume":"43","author":"Herzog","year":"1986","journal-title":"Arch Neurol"},{"issue":"5","key":"R56-13-20210128","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1528-1157.1988.tb03770.x","article-title":"Reproductive endocrine disorders in women with primary generalized epilepsy.","volume":"29","author":"Bilo","year":"1988","journal-title":"Epilepsia"},{"issue":"suppl 4","key":"R57-13-20210128","first-page":"42","article-title":"The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics.","volume":"63","author":"Ernst","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"R58-13-20210128","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1212\/WNL.34.10.1389","article-title":"Temporal lobe epilepsy: an extrahypothalamic pathogenesis for polycystic ovarian syndrome?","volume":"34","author":"Herzog","year":"1984","journal-title":"Neurology"},{"key":"R59-13-20210128","first-page":"53","article-title":"The neuroendocrine control of the menstrual cycle.","volume":"36","author":"Knobil","year":"1980","journal-title":"Recent Prog Horm Res"},{"issue":"2","key":"R60-13-20210128","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1212\/WNL.44.2.306","article-title":"Altered pulsatile secretion of luteinizing hormone in women with epilepsy.","volume":"44","author":"Drislane","year":"1994","journal-title":"Neurology"},{"issue":"10","key":"R61-13-20210128","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1212\/WNL.43.10.1907","article-title":"A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges in women with epilepsy.","volume":"43","author":"Herzog","year":"1993","journal-title":"Neurology"},{"issue":"4","key":"R62-13-20210128","first-page":"825","article-title":"Elevated serum LH and androgens in affective disorder related to the menstrual cycle: with reference to polycystic ovary syndrome.","volume":"47","author":"Matsunaga","year":"1993","journal-title":"Jpn J Psychiatry Neurol"},{"issue":"1","key":"R63-13-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1399-5618.2003.00010.x","article-title":"Menstrual cycle related mood changes in women with bipolar disorder.","volume":"5","author":"Rasgon","year":"2003","journal-title":"Bipolar Disord"},{"issue":"3","key":"R64-13-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4088\/JCP.v61n0305","article-title":"Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report.","volume":"61","author":"Rasgon","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"R65-13-20210128","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1157.1995.tb01045.x","article-title":"Menstrual disorders in women with epilepsy receiving carbamazepine.","volume":"36","author":"Isojarvi","year":"1995","journal-title":"Epilepsia"},{"issue":"4","key":"R66-13-20210128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410430406","article-title":"Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy.","volume":"43","author":"Isojarvi","year":"1998","journal-title":"Ann Neurol"},{"issue":"5","key":"R67-13-20210128","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ana.410390506","article-title":"Obesity and endocrine disorders in women taking valproate for epilepsy.","volume":"39","author":"Isojarvi","year":"1996","journal-title":"Ann Neurol"},{"issue":"4","key":"R68-13-20210128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(01)00806-3","article-title":"Altered ovarian function and cardiovascular risk factors in valproate-treated women.","volume":"111","author":"Isojarvi","year":"2001","journal-title":"Am J Med"},{"issue":"5","key":"R69-13-20210128","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1528-1157.2002.31501.x","article-title":"Serum insulin and leptin levels in valproate-associated obesity.","volume":"43","author":"Pylvanen","year":"2002","journal-title":"Epilepsia"},{"issue":"1-2","key":"R70-13-20210128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0920-1211(01)00317-5","article-title":"Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate.","volume":"48","author":"Luef","year":"2002","journal-title":"Epilepsy Res"},{"issue":"7","key":"R71-13-20210128","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00415-002-0731-3","article-title":"Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.","volume":"249","author":"Luef","year":"2002","journal-title":"J Neurol"},{"key":"R72-13-20210128","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.10391","article-title":"Predictors of ovulatory failure in women with epilepsy.","volume":"52","author":"Morrell","year":"2002","journal-title":"Ann Neurol"},{"issue":"9","key":"R73-13-20210128","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF03348013","article-title":"Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy.","volume":"20","author":"Murialdo","year":"1997","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"R74-13-20210128","first-page":"52","article-title":"Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy.","volume":"21","author":"Murialdo","year":"1998","journal-title":"Clin Neuropharmacol"},{"issue":"2-3","key":"R75-13-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0920-1211(03)00085-8","article-title":"Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy.","volume":"54","author":"Morrell","year":"2003","journal-title":"Epilepsy Res"},{"issue":"1","key":"R76-13-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0278-5846(02)00341-X","article-title":"Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women?","volume":"27","author":"Akdeniz","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"R77-13-20210128","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4088\/JCP.v63n0409","article-title":"Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder.","volume":"63","author":"O'Donovan","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R78-13-20210128","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1034\/j.1399-5618.2003.00009.x","article-title":"Valproate, bipolar disorder and polycystic ovarian syndrome.","volume":"5","author":"McIntyre","year":"2003","journal-title":"Bipolar Disord"},{"issue":"4","key":"R80-13-20210128","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0015-0282(16)54234-4","article-title":"Abnormal pattern of luteinizing hormone pulsatility in women with epilepsy.","volume":"55","author":"Bilo","year":"1991","journal-title":"Fertil Steril"},{"issue":"1","key":"R81-13-20210128","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1528-1157.2000.tb01502.x","article-title":"Lateral asymmetry in activation of hypothalamic neurons with unilateral amygdaloid seizures.","volume":"41","author":"Silveira","year":"2000","journal-title":"Epilepsia"},{"issue":"2","key":"R82-13-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0920-1211(02)00196-1","article-title":"GnRH-immunoreactive fiber changes with unilateral amygdala-kindled seizures.","volume":"52","author":"Friedman","year":"2002","journal-title":"Epilepsy Res"},{"issue":"5","key":"R83-13-20210128","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.410390503","article-title":"Polycystic ovarian syndrome in women with epilepsy: epileptic or iatrogenic?","volume":"39","author":"Herzog","year":"1996","journal-title":"Ann Neurol"},{"issue":"suppl 9","key":"R84-13-20210128","first-page":"287","article-title":"Reproductive endocrine characteristics of women with newly diagnosed or inadequately controlled epilepsy: a preliminary analysis.","volume":"44","author":"Borgohain","year":"2003","journal-title":"Epilepsia"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.jcp.0000125745.60149.c6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:47:00Z","timestamp":1620938820000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200406000-00013"}},"subtitle":["A Review of the Evidence"],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000125745.60149.c6","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}